Brief: Lumiradx Says Received $14.2 Mln In Grants From Bill&Melinda Gates Foundation For Ongoing Development Of Point Of Care Molecular Tuberculosis Testing System
14/12/2022 08:21
Dec 14 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX -RECEIVED $14.2M IN GRANTS FROM BILL&MELINDA
GATES
FOUNDATION FOR ONGOING DEVELOPMENT OF POINT OF CARE MOLECULAR
TUBERCULOSIS TESTING SYSTEM
Source text for Eikon: ID:nGNX8khHPX
Further company coverage: LMDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing